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Maternal recognition of pregnancy refers to the requirement for the conceptus (embryo and its associated extra-
embryonic membranes) to produce a hormone that acts on the uterus and/or corpus luteum (CL) to ensure
maintenance of a functional CL for production of progesterone; the hormone required for pregnancy in most
mammals. The pregnancy recognition signal in primates is chorionic gonadotrophin which acts directly on the CL
via luteinizing hormone receptors to ensure maintenance of functional CL during pregnancy. In ruminants,
interferon tau (IFNT) is the pregnancy recognition signal. IFNT is secreted during the peri-implantation period of
pregnancy and acts on uterine epithelia to silence expression of estrogen receptor alpha and oxytocin receptor
which abrogates the oxytocin-dependent release of luteolytic pulses of prostaglandin F2-alpha (PGF) by uterine
epithelia; therefore, the CL continues to produce progesterone required for pregnancy. Pig conceptuses secrete
interferon delta and interferon gamma during the peri-implantation period of pregnancy, but there is no evidence
that they are involved in pregnancy recognition signaling. Rather, pig conceptuses secrete abundant amounts of
estrogens between Days 11 to 15 of pregnancy required for maternal recognition of pregnancy. Estrogen, likely in
concert with prolactin, prevents secretion of PGF into the uterine venous drainage (endocrine secretion), but
maintains secretion of PGF into the uterine lumen (exocrine secretion) where it is metabolized to a form that is not
luteolytic. Since PGF is sequestered within the uterine lumen and unavailable to induce luteolysis, functional CL are
maintained for production of progesterone. In addition to effects of chorionic gonadotrophin, IFNT and estrogens
to signal pregnancy recognition, these hormones act on uterine epithelia to enhance expression of genes critical
for growth and development of the conceptus.
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Type I and type II interferons
Interferons are cytokines with antiviral, antiproli-
ferative and immunomodulatory biological effects crit-
ical to immune responses that protect the body against
viral infections and malignant cells [1]. Type I inter-
ferons with a high degree of structural homology
include interferons alpha (IFNA1-IFNA10, IFNA13,
IFNA14, IFNA16, IFNA17 and IFNA21), interferon
beta (IFNB), interferon delta (IFND), interferon epsilon
(IFNE), interferon kappa (IFNK), interferon tau (IFNT)
and interferon omega (IFNW1-IFNW3). IFNT is unique
in being the pregnancy recognition signal in ruminants.
The IFNT family of proteins are structurally andCorrespondence: fbazer@cvm.tamu.edu
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reproduction in any medium, provided the orfunctionally related to each other and to other type I in-
terferons and IFNT likely arose from duplication of an
IFNW gene some 36 million years ago when IFNT came
to be expressed in the trophectoderm under control of
an Ets-2/AP-1 enhancer element [2]. IFNT is expressed
only by mononuclear trophectoderm cells of ruminant
conceptuses (embryo and its extra-embryonic mem-
branes). IFND, another novel type I interferon is expressed
by conceptuses of pigs and horses during the peri-
implantation period of pregnancy [3]. Interferon gamma
(IFNG) is a type II interferon secreted by pig concep-
tuses during the peri-implantation period of pregnancy
[3]. The functions of IFND and IFNG from pig concep-
tuses are not known [4-6].
Type I IFNs bind a common receptor composed of
IFNAR1 and IFNAR2 to induce cell signaling via the
Janus activated kinases (JAKs) and tyrosine kinase 2is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Interferon tau (IFNT) is the pregnancy recognition
hormone in sheep and other ruminants that acts to silence
expression of estrogen receptor alpha (ESR1) and, in turn,
oxytocin receptor (OXTR) to prevent development of the
luteolytic mechanism that required oxytocin (OXT) from the
corpus luteum (CL) and posterior pituitary to induce luteolytic
pulses of prostaglandin F2α (PGF). Thus, IFNT blocks the ability of
the uterus to develop the luteolytic mechanism, but does not inhibit
prostaglandin synthase 2 (PTGS2) or the basal production of PGF
during pregnancy.
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formation of signal transducer and activator or tran-
scription homodimers (STAT1–STAT1) known as gamma-
activation factor (GAF) that translocate to the nucleus
and bind GAS (gamma-activation site) elements in the
promoter region of interferon stimulated genes (ISG).
One GAS-regulated gene is interferon regulatory factor
1(IRF1) which binds and activates interferon stimulated
response elements (ISREs) of many ISG to amplify ef-
fects of type I IFNs [9,10]. However, type I IFNs act pre-
dominantly via interferon stimulatory gene factor 3
gamma (ISGF3G) rather than GAF. The ISGF3G com-
plex includes the STAT1: STAT2 heterodimer and IRF9.
The predominant cell signaling pathways involve STAT2
and ISGF3G that prolong effects of IFNT by increasing
expression of STAT2 and IRF9 which favors formation
of ISGF3G rather than GAF [11,12]. However, type I
IFNs also activate non-classical cell signaling pathways
that include mitogen activated protein kinases (MAPKs),
especially p38 and ERK1/2, as well as the phosphatidyl in-
ositol kinase 3 kinase (PI3K)/V-AKT murine thymoma
viral oncogene homolog 1 (AKT1) pathway and mechanis-
tic target of rapamycin (MTOR) [1,13].
IFNG is critical for innate and adaptive immunity
against viral and intracellular bacterial infections and
tumor control, as well as activating macrophages. The im-
portance of IFNG in immunology derives from its ability
to inhibit viral replication directly and exert immu-
nostimulatory and immunomodulatory effects. IFNG is
produced by natural killer and natural killer T cells in in-
nate immune responses and by CD4 Th1 and CD8 cyto-
toxic T lymphocyte effector T cells after development of
antigen-specific immunity [14]. IFNG induces cellular re-
sponses via its interaction with a heterodimeric receptor
consisting of IFNG receptor 1 (IFNGR1) and IFNGR2
which activates the JAK-STAT pathway. IFNG also binds
to heparan sulfate at the cell surface which inhibits its bio-
logical activity [14].
Characteristics of interferon Tau
IFNT was discovered by culturing sheep conceptuses in
the presence of radiolabeled amino acids and detecting
radiolabeled de novo synthesized proteins that included
an abundant low molecular weight protein first named
protein X and then ovine trophoblast protein 1 [15-18]
in my laboratory and trophoblastin by Martal et al. [19].
When the gene for oTP1/trophoblastin was cloned and
sequenced it was found to be a type 1 interferon desig-
nated IFNT [20,21]. The antiviral, antiproliferative and
immunosuppressive activities, and insight into its struc-
tural motif have been reported [22-25]. My laboratory
used a synthetic gene for IFNT to produce recombinant
IFNT with immunosuppressive, antiviral, antiprolife-
rative and antiluteolytic properties identical to those fornative IFNT [26,27]. IFNT has a molecular weight of 19
to 24 kDa depending on glycosylation and an isoelectric
point between 5.3 and 5.8. It has 172 amino acids with
disulfide bridges between cysteine residues at 1 and 99,
as well as 29 and 139 [28]. Ovine IFNT is not glyco-
sylated, whereas bovine IFNT is N- glycosylated and
caprine IFNT is a mixture of nonglycosylated and
N-glycosylated forms with the glycosylation site being
at ASN 78. The amino terminal amino acid is proline.
IFNT is very stable to pH as low as 2 to 3 [28].
Antiluteolytic effects of interferon Tau
The model for studies of the antiluteolytic effect of IFNT
in my laboratory was based on McCracken’s model of the
“progesterone block” for regulation of the estrous cycle in
ewes [29]. The hypothesis states that P4 blocks expression
of estrogen receptor alpha (ESR1) and oxytocin receptor
(OXTR) for about 10 days after which time P4 down-
regulates expression of progesterone receptors (PGR) in
uterine epithelia which allows rapid increases in expres-
sion of ESR1 and OXTR genes (Figure 1). Then, pulsatile
release of oxytocin (OXT) from the posterior pituitary
gland and CL induce pulsatile secretion of prostaglandin
F2α (PGF) from uterine epithelia on Days 15 and 16 which
induces functional and structural regression of the CL
followed by estrus and another opportunity for the ewe to
mate and become pregnant. Our understanding of preg-
nancy recognition in ruminants is from studies see [30-32]
indicating that: 1) IFNT silences transcription of the ESR1
Figure 2 Silencing expression of progesterone receptor (PGR)
in uterine epithelia is a prerquisite for implantation in
mammals. Therefore, progesterone (P4) acts via PGR-positive
uterine stromal cells to increase expression of progestamedins, e.g.
fibroblast growth factor-7 (FGF7) and FGF10, as well as hepatocyte
growth factor (HGF) in sheep uteri. The progestamedins, as well as
interferon tau (IFNT) exert paracrine effects on uterine epithelia and
conceptus trophectoderm that express receptors for FGF7 and
FGF10 (FGFR2IIIb) and HGF (MET) to stimulate cell signaling pathways
including phosphatidyl inositol kinase 3 kinase (PI3K) and mitogen
activated protein kinase (MAPK) to stimulate gene expression and
secretory responses by trophectoderm and uterine luminal (LE) and
superficial glandular (sGE) epithelia that do not express signal
transducers and activators of transcription (STAT1/STAT2). Thus, IFNT
activates undefined alternate cell signaling pathways that may
include PI3K and MAPK to influence gene expression by uterine LE
and sGE.
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in uterine luminal and superficial glandular epithelia
(LE/sGE) to abrogate development of the endometrial
luteolytic mechanism involving OXT-induced luteolytic
pulses of PGF; 2) basal production of PGF and PGE2 is
higher in pregnant than cyclic ewes due to continued ex-
pression of prostaglandin synthase 2 (PTGS2) in uterine
LE/sGE; 3) IFNT silencing of ESR1 expression prevents
estradiol from inducing PGR in endometrial epithelia; and
4) loss of PGR by uterine epithelia is required for expres-
sion of P4-induced and IFNT-stimulated genes that sup-
port development of the conceptus. Caprine IFNT secreted
between Days 16 and 21 of gestation also abrogates the
luteolytic mechanism to prevent pulsatile release of
luteolytic PGF and extend lifespan of the CL in goats [33].
Bovine IFNT, secreted between Days 12 and 38 of preg-
nancy, also prevents secretion of luteolytic pulses of PGF
by uterine epithelia and blocks effects of exogenous E2 and
oxytocin to stimulate uterine release of PGF. Expression of
ESR1 and OXTR mRNAs is either silenced or the receptors
are not responsive to estradiol and OXT in endometria of
both pregnant cows and cyclic cows treated with intrauter-
ine injections of either ovine or bovine recombinant or na-
tive IFNT see [34,35].
IFNT silences expression of ESR1 to ensure that estra-
diol does not increase expression of ESR1 in uterine epi-
thelia during pregnancy. Thus, uterine LE/sGE do not
express ESR1, PGR, IRF9 or STAT1 because IFNT in-
duces expression of IRF2, a potent suppressor of tran-
scription, in uterine LE/sGE that is in direct contact
with conceptus trophectoderm [31]. Therefore, uterine
LE/sGE in direct contact with the conceptus express
unique non-classical interferon stimulated genes such as
those for transport of nutrients into the uterine lumen
to support growth and development of the conceptus.
The uterine LE/sGE are affected by P4; however, the ac-
tion of P4 is mediated by PGR-positive uterine stromal
cells that secrete one or more progestamedins, parti-
cularly FGF10 in ewes, and effects of IFNT on uterine
LE/sGE are mediated via a JAK/STAT-independent cell
signaling pathway [3,30,31]. Therefore, IFNT abrogates
the uterine luteolytic mechanism to prevent pulsatile re-
lease of luteolytic PGF while also increasing expression
of many genes critical for uterine receptivity to implant-
ation and conceptus development (Figure 2). These
genes include wingless-type MMTV integration site
family member 7A (WNT7A) induced by IFNT, as well
as LGALS15 (galectin 15), CTSL (cathepsin L), CST3
(cystatin C), SLC2A1 (solute carrier family 2 (facilitated
glucose transporter), member 1), SLC7A2 (cationic
amino acid transporter), HIF2A (hypoxia-inducible fac-
tor 2A) and gastrin releasing peptide (GRP) that are in-
duced by P4 and further stimulated by IFNT and/or
prostaglandins [30].Prostaglandins and IFNT affect uterine gene expression
and conceptus development
Dorniak et al. [36] reported that prostaglandins (PG) se-
creted by epithelial and stromal cells of the uterus effect
expression of genes critical to elongation and implantation
of the ovine conceptus. Although IFNT inhibits expres-
sion of ESR1 and OXTR in uterine LE/sGEof pregnant
ewes, IFNT does not inhibit expression of prostaglandin
synthase 2 (PTGS2), the rate-limiting enzyme in synthesis
of PGs. IFNT stimulates PGE2 production by cells of the
bovine uterus and other Type I IFNs stimulate phospho-
lipase A2 (PLA2) and synthesis of PGE2 and PGF in vari-
ous cell types. Intra-uterine infusions of meloxicam, a
specific inhibitor of PTGS2, prevents elongation of ovine
conceptuses. The elongating conceptuses of ewes and
cows synthesize and secrete more PGs than the uterus;
therefore, the abundance of PGs is greater in the uterine
lumen of pregnant as compared to cyclic ewes and cows.
Sheep conceptuses secrete mainly PGF, 6-keto-PGF1α
(i.e., a stable metabolite of PGI2), and PGE2 during the
peri-implantation period of pregnancy and PG receptors
are present in all cell types of the uterus and conceptus
during pregnancy. Conceptus-derived PGs have autocrine,
paracrine and possibly intracrine effects on cells of the
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PTGS2 by Day 7 bovine blastocysts predicts successful de-
velopment of that blastocyst to term and delivery of a live
calf. The infusion of PGE2, PGF, PGI2 or IFNT into the
uterine lumen of cyclic ewes increases expression of GRP,
insulin-like growth factor binding protein 1 (IGFBP1) and
LGALS15, but only IFNT increases expression of cystatin
6 (CST6). Differential effects of PGs were also observed
for CTSL and its inhibitor CST3. For glucose transporters,
IFNT and all PGs increased SLC2A1, but only PGs
increased SLC2A5 expression, whereas expression of
SLC2A2 and SLC5A1 mRNAs were increased by IFNT,
PGE2, and PGF. Infusions of all PGs and IFNT increased
the amino acid transporter SLC1A5, but only IFNT in-
creased SLC7A2. In the uterine lumen, only IFNT in-
creased glucose concentrations, and only PGE2 and PGF
increased the abundance of total amino acids. Thus, PGs
and IFNT coordinately regulate endometrial functions im-
portant for growth and development of the conceptus dur-
ing the peri-implantation period of pregnancy.Cortisol regulates endometrial function
The expression of 11-beta-hydroxysteroid dehydrogenase,
type I (HSD11B1) is induced by P4 and stimulated by
IFNT in ovine uterine LE/sGE and it is one of two
isoforms that regulate intracellular levels of bioactive glu-
cocorticoids. The ovine uterine endometrium and concep-
tus generate active cortisol from inactive cortisone and
cortisol regulates expression of genes via the glucocortic-
oid receptor (GR). The few GR target genes identified in
the uterus or placenta include those involved in lipid me-
tabolism and triglyceride homeostasis. In addition to pro-
gesterone induction and IFNT stimulation of HSD11B1
expression in the ovine endometrium, PGs regulate activ-
ity of HSD11B1 in the bovine endometrium, and PGF
stimulates HSD11B1 activity in human fetal membranes
[36-38]. Elongating sheep conceptuses generate cortisol
from cortisone via HSD11B1. GR are present in all cells of
ovine uterus during the estrous cycle and pregnancy and
in conceptus trophectoderm; therefore, cortisol may have
paracrine and autocrine effects on the endometrium and
conceptus trophectoderm. Intrauterine infusions of corti-
sol into cyclic ewes from Days 10 to 14 increased expres-
sion of several elongation- and implantation-related genes
in ovine uterine epithelia. In humans, cortisol at the
conceptus-maternal interface is proposed to stimulate se-
cretion of chorionic gonadotropin by trophoblast, pro-
mote trophoblast growth and invasion, and stimulate
placental transport of glucose, lactate, and AA. Interest-
ingly, administration of glucocorticoids increased preg-
nancy rates in women undergoing assisted reproductive
technologies and pregnancy outcomes in women with a
history of recurrent miscarriage [39,40].Interferon Tau drives a servomechanism for uterine
functions
The establishment and maintenance of pregnancy requires
integration of endocrine and paracrine signals from the
ovary, conceptus, and uterus [41]. In ewes, implantation
and placentation occur as a protracted process from Days
15–16 to Days 70 to 80 of pregnancy [42,43]. During this
period, the uterus and placenta grow and remodel for sup-
port of rapid conceptus development and growth during
the last one-half of pregnancy [44]. In addition to develop-
ment of placentomes in the caruncular areas of the endo-
metrium and changes in uterine vascularity, the uterine
glands in the intercaruncular endometrium increase in
length (4-fold) and width (10-fold) and degree of second-
ary and tertiary branching during pregnancy [42]. Hyper-
plasia of uterine GE occurs between Days 15 and 50 to 60
of gestation and then uterine glands undergo hypertrophy
to increase surface area for maximal production of
histotroph after Day 60 [45].
The ovine uterus is exposed sequentially to estrogen,
progesterone, IFNT, placental lactogen (CSH1), and pla-
cental growth hormone (GH1) during pregnancy as
these hormones initiate and maintain endometrial gland
morphogenesis and differentiated secretory functions of
uterine GE [46]. Ovine CSH1 is produced by binucleate
cells of conceptus trophectoderm from Days 15 or 16 of
pregnancy which is coordinate with onset of expression
of genes for uterine milk proteins (UTMP) and secreted
phosphoprotein 1 (SPP1, also known as osteoponin) by
uterine GE [45,47]. UTMP are members of the serpin
family of serine protease inhibitors [48] and SPP1 is
an extra-cellular matrix protein [49]. UTMP and SPP1
are excellent markers for differentiation and overall
secretory capacity of uterine GE during pregnancy in
ewes [46]. CSH1 is detectable in maternal serum by Day
50 and peak concentrations are between Days 120 to
130 of gestation [50]. A homodimer of the prolactin re-
ceptor (PRLR) and a heterodimer of PRLR and growth
hormone receptor (GHR) transduce CSH1 cell signaling
[51]. In the ovine uterus, CSH1 binding sites for PRLR
are specific to GE [52]. Temporal changes in circulating
levels of CSH1 are correlated with endometrial gland
hyperplasia and hypertrophy and increased production
of UTMP and SPP1 during pregnancy [45,49]. Placental
GH1 is produced between Days 35 and 70 of gestation
[53] when onset of hypertrophy of uterine GE occurs
along with maximal increases in the abundance of
UTMP and SPP1 proteins from uterine GE. Thus, two
members of the lactogenic and somatogenic hormone
family stimulate endometrial gland morphogenesis and
differentiated function during pregnancy to facilitate
conceptus growth and development in ewes.
The sequential exposure of the ovine uterus to es-
trogen, progesterone, IFNT, CSH1 and placental GH1
Bazer Journal of Animal Science and Biotechnology 2013, 4:23 Page 5 of 10
http://www.jasbsci.com/content/4/1/23during pregnancy constitutes a “servomechanism” that
activates and maintains remodeling, secretory function
and growth of the uterus [46]. Chronic treatment of
ovariectomized ewes with progesterone induces expres-
sion of UTMP and CSH1 by uterine GE and insures that
PGR are not in uterine epithelia beyond Day 13 post-
estrus [41]. Down-regulation of PGR in uterine GE is re-
quired for progesterone to induce expression of UTMP
and SPP1, but a combination of progesterone and estro-
gen increases expression of ESR1 and PGR in uterine
GE which inhibits expression of both SPP1 and UTMP.
Thus, progesterone must down-regulate expression of
PGR in uterine GE in order for CSH1 and GH1 to
stimulate expression of UTMP and SPP1 [46].
The intrauterine infusion of CSH1 or GH1 increases
expression of UTMP and SPP1 by uterine GE of
progesterone-treated ewes. However, the ewes must first
receive intrauterine infusions of IFNT between Days 11
and 21, and then either CSH1 or GH1 from Days 16 to
29 after onset of estrus [46]. The increase in expression
of UTMP by uterine GE is due in part to effects of
CSH1 and GH1 to increase branching and surface area
of uterine glands. Intrauterine infusion of CSH1 and
GH1 into ewes treated with progesterone and IFNT in-
creased hypertrophy of uterine glands, but this response
did not occur if ewes were not treated with IFNT prior
to receiving intra-uterine infusions of CSH1 or GH1.
The ability of prolactin, CSH1 and GH1 to elicit similar
effects on uterine glands is consistent with the fact that
these hormones are members of a unique hormone fam-
ily that shares genetic, structural, binding, receptor
signal transduction and function on glandular tissues in-
cluding the uterus and mammary gland [51]. These
studies revealed that developmentally programmed
events mediated by specific paracrine-acting hormones
at the conceptus-uterine interface stimulate remodeling
and differentiated function of uterine GE for production
of histotroph essential for fetal-placental growth during
gestation. Importantly, actions of IFNT, through an un-
known mechanism, are required for actions of CSH1
and GH1 on uterine gland development and function.
Pregnancy recognition signaling in pigs
The blastocysts of pigs undergo a morphological transition
from large spheres of 10 to 15 mm diameter and then
tubular (15 mm by 50 mm) and filamentous (l mm by
100–200 mm) forms between Days 10 and 12 of preg-
nancy and achieve a length of 800 to 1000 mm between
Days 12 and 15 of pregnancy see [31]. Rapid elongation of
conceptus trophectoderm allows maximum surface area
of contact between trophectoderm and uterine LE/sGE.
During this period of rapid elongation, the trophectoderm
secretes estrogens (catecholestrogens, estrone and estra-
diol) [54], and IFNG and IFND [4,5]. Estrogen is thepregnancy recognition signal from conceptus trophecto-
derm in pigs and it must be secreted between Days 11 and
15 of pregnancy. Estrogen does not inhibit secretion of
PGF by uterine endometrium, rather it activates a mech-
anism whereby secretion of PGF is into the uterine lumen
(exocrine secretion) rather than into the uterine vascula-
ture (endocrine secretion) as occurs in nonpregnant gilts
and sows (Figure 3). Thus, in pregnant pigs, PGF is se-
questered within the uterus and metabolized to prevent it
from exerting luteolytic effects on the CL. The conceptus
estrogens also modulate expression of genes responsible
for endometrial remodeling for implantation between
Days 13 and 25 of gestation [55]. Both SPP1 and FGF7 are
induced by estrogen in uterine LE to affect trophectoderm
and LE adhesion, signal transduction and cell migration
during the peri-implantation period [56-58]. The troph-
ectoderm also secretes interleukin 1 beta (IL1B) during
this period and estrogen appears to modulate uterine
responses to IL1B [59].
Pig conceptus trophectoderm secretes both IFNG and
IFND during the peri-implantation period of pregnancy
[4,5]. IFNG mRNA is abundant in trophectoderm be-
tween Days 13 and 20 of pregnancy, whereas IFND
mRNA is detectable in Day 14 conceptuses only by RT-
PCR analysis [54]. IFNG and IFND proteins co-localize
to peri-nuclear membranes typically occupied by the
endoplasmic reticulum and golgi apparatus, as well as
cytoplasmic vesicles within clusters of trophectoderm
cells along the uterine LE. This expression is character-
ized by de novo appearance of zona occludens one
(ZO1), a marker of epithelial tight junctions on their
basal aspect which suggests changes in endometrial po-
larity [5]. There is no evidence that either IFNG or IFND
have antiluteolytic effects to prevent regression of CL or
alter concentrations of progesterone in plasma. However,
they do stimulate secretion of PGE2 by uterine cells
which may enhance structural integrity of CL and their
secretion of P4 [60].
A number of genes are expressed by uterine epithelial
and stromal cells in pigs in response to intra-muscular in-
jections of estradiol and/or intra-uterine injections of pig
conceptus secretory proteins that include IFNG and IFND
[61-63]. Implantation in pigs is non-invasive and pigs have
a true epitheliochorial placenta. Genes induced in uterine
LE by estrogen include SPP1, FGF7, aldo-keto reducing
family 1 member B1 (AKR1B1), cluster of differentiation
24 (CD24), neuromedin beta (NMB), STAT1 and IRF2.
Expression of IRF2 is induced in uterine LE/sGE by estro-
gen, the pregnancy recognition signal in pigs whereas
IFNT induces IRF2 in uterine LE/sGEin ewes. In both pigs
and ewes the expression of IRF2 in uterine LE and sGE
prevents IFNT in ewes and IFNG and IFND in pigs from
inducing expression of ISG in uterine LE/sGE. The genes
expressed by uterine LE of pigs are for stimulation of
Figure 3 The theory of pregnancy recognition in the pig is that secretion of prostaglandin F2α (PGF) is endocrine, that is, toward the
uterine vascular drainage to induce luteolysis in cyclic pigs. However, PGF is secreted in an exocrine direction, that is, toward the uterine
lumen in pregnant pigs where it is metabolized and unavailable to exert luteolytic effects.
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to uterine LE. Also, IFND and/or IFNG may affect blas-
tocyst attachment to uterine LE in pigs by inducing
labilization and remodeling of uterine LE to affect polarity
and stimulate production of PGE2.
Since IRF2 is expressed in uterine LE of pigs, these
cells do not express classical ISG, rather expression of
classical ISG is limited to uterine GE and stromal cells
[66]. The classical ISG induced by IFNG and/or IFND in
uterine GE and stromal cells, as well as endothelial cells
include STAT1, STAT2, IRF1, MX1, swine leukocyte an-
tigens (SLA) 1–3 and 6–8, and beta 2 microglobulin.
The pregnancy-specific roles of these uterine ISGs may
be to: 1) affect decidual/stromal remodeling to protect
the fetal semi-allograft from immune rejection; 2) limit
conceptus invasion into the endometrium; and/or 3)
stimulate development of uterine vasculature. Because
IFNG can initiate development of the endometrial vas-
culature, it is hypothesized to facilitate establishment of
hematotrophic support of developing conceptuses.
Secretion of both IFND and IFNG by conceptus
trophectoderm is unique to pig conceptuses, but little is
known of their interactions. Type I IFND and Type II
IFNG may each induce expression of non-overlapping
sets of genes; however, they may act synergistically to in-
duce physiological responses. Cooperative induction and
maintenance of expression of ISGs such as STAT1 for
reinforcement of their effects on distinct cell-surface li-
gands while maintaining their individual specificities forinducing ISGs may occur. Although IFNG may enhance
uterine receptivity to implantation in pigs, highly local-
ized and abundant expression of IFNG, TNFA, IL1B and
IL1R in the endometrium is reported to interfere with
conceptus development between Days 15 and 23 of
pregnancy [64].
Progestamedins, estramedins, corticoids and prostaglandins
Uterine receptivity to implantation is dependent on pro-
gesterone which is permissive to actions of IFNs, chori-
onic gonadotrophin and lactogenic hormones such as
prolactin and placental lactogen [2,30-32]. The paradox
is that cessation of expression of PGR and ESR1 by uter-
ine epithelia is a prerequisite for uterine receptivity to
implantation, expression of genes for secretory proteins
by uterine epithelia, and selective transport of molecules
into the uterine lumen that support conceptus develop-
ment. Down-regulation of PGR is associated with loss of
expression of proteins on uterine LE such as MUC1
which would interfere with implantation. Further, silen-
cing expression of PGR in uterine epithelia allows pro-
gesterone to act on PGR-positive uterine stromal cells
to induce expression of progestamedins, i.e., FGF7
and −10, and hepatocyte growth factor (HGF), that exert
more specific paracrine regulation of differentiated func-
tions of uterine epithelia and conceptus trophectoderm
that express receptors for FGF7 (FGFR2IIIb) in pigs see
[30]. Many ISGs are P4-induced and IFN-stimulated;
however, a fundamental unanswered question is whether
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or other uterine cell types involve non-classical cell sig-
naling pathways, independent of PGR and STAT1, such
MAPK and PI3K/AKT to affect gene expression and
uterine receptivity to implantation [1,30]. Interestingly,
type I IFNs bind the same receptor, but activate unique
signaling pathways that are cell-specific to differentially
affect gene expression in uterine LE/sGE versus GE and
stromal cells [55,64,65].
Estramedins in pigs
Pig conceptuses secrete estrogens between Days 10 and
15 for pregnancy recognition, but also to increase ex-
pression of growth factors including insulin-like growth
factor 1 (IGFI) and FGF7 which, in turn, act on concep-
tus trophectoderm to stimulate proliferation and/or
gene expression [32]. IGFI is expressed by uterine
glands of cyclic and pregnant pigs and IGF1 receptors
(IGF1R) are expressed by cells of the endometrium and
conceptuses suggesting paracrine and autocrine actions
of IGFI. FGF7, an established paracrine mediator of
hormone-regulated epithelial growth and differen-
tiation, is expressed uniquely by uterine LE in pigs
between Days 12 and 20 of the estrous cycle and preg-
nancy. FGF7 binds to and activates FGFR2IIIb expressed
by uterine epithelia and conceptus trophectoderm. Es-
tradiol increases FGF7 expression following effects of
progesterone to down-regulate expression of PGR in
uterine LE. FGF7 then increases cell proliferation, phos-
phorylated FGFR2IIIb, the MAPK cascade and expres-
sion of urokinase-type plasminogen activator, a marker
for trophectoderm cell differentiation [56,59]. From
about Day 20 of pregnancy, FGF7 expression shifts from
uterine LE to uterine GE in pigs and likely continues to
affect uterine epithelia and conceptus development
[57,58]. In addition to the increase in secretion of estro-
gens between Days 11 and 15 of pregnancy for maternal
recognition of pregnancy, increases in estrogens from
the placenta between Days 20 and 30 increase expres-
sion of endometrial receptors for prolactin that may
allow prolactin to stimulate secretions from uterine GE,
placentation and uterine blood flow for increased trans-
port of nutrients [66].
Corticoids
There are positive actions of glucocorticoids in early preg-
nancy. For example, in primates, glucocorticoids stimulate
secretion of chorionic gonadotrophin, suppressuterine
natural killer cells, and promote trophoblast growth and
invasion, as well as exert negative effects that might
compromise pregnancy that include inhibiting cytokine-
prostaglandin signaling, restriction of trophoblast invasion,
induction of apoptosis, and inhibition of conceptus devel-
opment [67]. With respect to implantation of blastocysts,a dialogue initiated by cell surface signalling molecules on
conceptus trophectoderm and uterine LE includes
integrins and fibronectin that glucocorticoids suppress to
enhance implantation. The effects of glucocorticoids on
fibronectin expression are tissue-specific with dexame-
thasone suppressing fibronectin in term human cyto-
trophoblasts and amnion, but acting in synergy with
transforming growth factor beta to increase expression of
fibronectin in matched samples of chorion and placental
mesenchymal cells. Also occurring during the peri-
implantation period of pregnancy are events mediated by
pro-inflammatory cytokines such as IL1B, TNFA and
prostaglandins that are modulated by anti-inflammatory
effects of glucocorticoids which likely modulate cytokine-
prostaglandin signaling required for implantation. Both
IL1B and TNFA increase expression and activity
11BHSD1 while suppressing expression of 11BHSD2 in
term human chorionic trophoblasts. This has the net
effect of increasing the conversion of corticosterone to
cortisol and creating a negative feedback loop at the
uterine-conceptus interface between glucocorticoids and
inflammatory cytokines.
In most tissues, one aspect of the anti-inflammatory ef-
fect of glucocorticoids is to inhibit the synthesis of prosta-
glandins and thromboxanes by decreasing the expression
and/or actitivity of phospholipase A2 (PLA2) and, there-
fore, liberation of arachidonic acid as substrate for PTGS1
and PTGS2 [68]. However, in the placenta, glucocorticoids
increase PLA2, PTGS2 and prostaglandin synthases [69]
and decrease expression of 15-alpha hydroxyprostaglandin
dehydrogenase (HPGD) that converts prostaglandins to
their inactive forms [70]. Within the placenta, prostaglan-
dins increase expression and activity of 11BHSD1 [37] to
increase cortisol production and decrease activity of
11BHSD2 that converts cortisol to inactive cortisone [71].
Glucocorticoids can stimulate growth of trophoblast and
expression of pro-matrix metalloproteinase (proMMP-2)
[72], but other reports indicate that they inhibit expression
of MMP9 and migration (invasiveness) of cytotrophoblast
cells [73]. Further, glucocorticoids affect degradation of
extracellular matrix during trophoblast invasion with
urokinase-type plasminogen activator (uPA) that leads to
plasmin-associated degradation of extracellular matrix and
tissue-type enzyme (tPA) plasmin-dependent breakdown
of fibrin for establishment of an efficient vascular ex-
change in the placenta [74]. The activities of both uPA
and tPA are inhibited by plasminogen activator inhibitor
(PAI1) secreted by trophoblast and decidual cells [75] and
both cortisol and dexamethasone increase expression of
PAI1 [76] which may result in poor placental exchange of
nutrients and gases and lead to pre-eclampsia and intra-
uterine growth retardation [77].
In sheep, establishment of pregnancy requires elong-
ation of the conceptus and production of IFNT for
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Expression of HSD11B1 may be stimulated by P4, pros-
taglandins and/or cortisol and HSD11B1 mRNA is more
abundant in uterine LE/sGE between Days 12 and 16 of
pregnancy than the estrous cycle and expression of both
HSD11B1 and PTGS2 by uterine LE/sGE is coordinate
with conceptus elongation in ewes [78]. Physiological
levels cortisol are also potent stimulators of expression
of both arginase and ornithine decarboxylase in cells
which increases synthesis of polyamines essential for cell
proliferation and differentiation of cells of the conceptus
[79]. Although HSD11B1 is abundant in the uterine epi-
thelia, it is barely detectable in the conceptus, whereas
HSD11B2 is barely detectable in uterine epithelia, buta-
bundant in the conceptus. Expression of HSD11B1 is in-
duced by P4 and further stimulated by IFNT in uterine
LE/sGE. The corticoid receptor, NR3C1, is present in all
ovine uterine cell types. Therefore, HSD11B1 expression
in uterine LE/sGE is regulated by P4, IFNT and prosta-
glandins generate cortisol that act via NR3C1 to regulate
ovine endometrial functions, such as production of pros-
taglandins, during pregnancy. Prostaglandins represent
another activator of gene expression via their respective
receptors, such as PGE receptors (PTGER1-PTGER3) to
activate MAPK cell signaling pathways. In bovine uteri,
IFNT stimulates expression of PTGS2 and PGE synthase
to increase the relative abundance of PGE, but also in-
creases expression of prostaglandin E receptor 2, EP2
subtype in endometrial epithelia [80] and PGE may
stimulate gene expression by activation of p38 MAPK
[81]. Therefore, in uterine epithelia, there is the potential
for IFNT, progestamedins and prostaglandins to act ad-
ditively or synergistically to stimulate expression of
genes by uterine epithelia that support growth and de-
velopment of the conceptus.
Summary
The focus of this review is pregnancy recognition signal-
ing molecules in ruminants by IFNT and in pigs by es-
trogens. IFNT abrogates development of the luteolytic
mechanism by silencing expression of ESR1 and OXTR
to prevent pulsatile release of luteolytic PGF by uterine
epithelia. Estrogens from pig conceptuses, on the other
hand, induce mechanisms for exocrine secretion of PGF
into the uterine lumen where is metabolized and, there-
fore, unavailable to cause luteolysis. Both IFNT and es-
trogens, in concert with effects of progesterone, exert
effects particularly on uterine LE and sGE the increase
expression of genes that include growth factors and nu-
trient transporters critical to growth and development of
the conceptus. The PGs and corticoids within the uter-
ine lumen also play important roles in regulation of gene
expression favorable to a uterine environment support-
ive of conceptus development. The complex interactionsbetween hormones from the ovaries, conceptus troph-
ectoderm/placenta and maternal pituitary are discussed
with respect to effects on growth and development of
uterine glands that secretion of nutrients critical to con-
ceptus development. Collectively, the outcome of actions
of the many hormones, growth factors, cytokines, lym-
phokines, extra-cellular matrix and nutrients is highly
conducive to a successful outcome of pregnancy that in-
cludes establishment of mechanisms whereby the con-
ceptus semi-allograft is protected from the maternal
immune system.
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